nk3201 has been researched along with angiotensin i in 1 studies
Studies (nk3201) | Trials (nk3201) | Recent Studies (post-2010) (nk3201) | Studies (angiotensin i) | Trials (angiotensin i) | Recent Studies (post-2010) (angiotensin i) |
---|---|---|---|---|---|
18 | 0 | 1 | 4,218 | 125 | 1,253 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishida, K; Jin, D; Kamoshita, K; Miyazaki, M; Nishimoto, M; Sakaguchi, M; Sasaki, S; Sukenaga, Y; Takai, S; Yuda, A | 1 |
1 other study(ies) available for nk3201 and angiotensin i
Article | Year |
---|---|
Oral administration of a specific chymase inhibitor, NK3201, inhibits vascular proliferation in grafted vein.
Topics: Acetamides; Administration, Oral; Angiotensin I; Animals; Carotid Arteries; Cell Division; Chymases; Culture Techniques; Dogs; Drug Antagonism; Graft Occlusion, Vascular; Muscle Contraction; Peptidyl-Dipeptidase A; Pyrimidines; Serine Endopeptidases; Serine Proteinase Inhibitors; Species Specificity; Veins | 2001 |